FDA public health advisory: low molecular-weight heparin and spinal/epidural anesthesia or spinal puncture.
Lumpkin
M M
MM
Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, USA.
D000767:Anesthesia, Epidural / Q000009:adverse effects*; D000775:Anesthesia, Spinal / Q000009:adverse effects*; D006406:Hematoma / Q000139:chemically induced*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects* / Q000600:supply & distribution; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
D006495:Heparin, Low-Molecular-Weight